Purchase Order 75F40126P00289

This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned for-profit manufacturer of specialized laboratory equipment. The $218,346.00 contract is for the Maestro Multiwell System and related service agreement. Axion Biosystems provides the FDA with its proprietary Maestro multi-electrode array (MEA) systems, Maestro Apex automated incubators, and consumables to support the agency's biomedical research and drug...

<p>The Food and Drug Administration issued a delivery order to Axion Biosystems, Inc. on August 18, 2026, with a ceiling value of $51,900 for Axion multi-well plates for use in the multielectrode array (MEA) Maestro system. The order is firm fixed price and completes on September 30, 2026. Place of performance is Atlanta, Georgia.</p>

This is a $140,204.00 firm-fixed-price purchase order contract awarded by the U.S. Department of Health and Human Services' Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of goods. The contract is for the delivery of a Micro-Electrode Assay System, a specialized laboratory instrument used in biomedical research initiatives across agencies like the National Institutes of Health (NIH), EPA, and VA. As a small business set-aside, this award...

This is a $23,690.00 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of advanced laboratory equipment based in Atlanta, Georgia. The contract is for the procurement of laboratory supplies and consumables to support the FDA's Center for Drug Evaluation and Research (CDER). This award is a small business set-aside and is not associated with a larger contract vehicle. Axion Biosystems has a history...

This federal contract award is for the procurement of microelectrode array (MEA) lab equipment, including the Maestro multi-well MEA system, from Axion Biosystems, Inc. The $163,750.00 firm fixed-price purchase order was issued by the Department of Health and Human Services' Food and Drug Administration. The contract has a completion date of December 1, 2022 and includes two 1-year post-warranty maintenance option periods. Axion Biosystems is a life science company that develops technologies for...

This federal contract award, with ID HHSF223201510126A, was made by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment and instruments. The $219,708.00 firm-fixed-price purchase order is for the acquisition of a high-throughput microelectrode assay system, plus 4 years of preventive maintenance services. The award does not have a set-aside designation. Axion Biosystems is a provider of live cell...

<p>The Food and Drug Administration awarded a purchase order to Axion Biosystems, Inc. for a multielectrode array system valued at $285,745.00 on September 8, 2025. No set-aside applied. Place of performance is Silver Spring, Maryland. The order carries a firm fixed price and an ultimate completion date of September 4, 2030.</p>

<p>The National Center for Advancing Translational Sciences awarded a purchase order to Axion Biosystems, Inc. for a service and maintenance agreement covering an Axion Biosystems instrument, valued at $110,200.00, on September 14, 2024. Performance is located in Atlanta, Georgia. The order is priced on a firm fixed price basis with an ultimate completion date of September 13, 2025.</p>

This is a $669,000.00 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Axion Biosystems, Inc. for a service agreement to provide preventative maintenance, repairs, updates, and loaner units for multiple Axion Biosystems microelectrode array instruments and liquid handling robot components located at NCATS' facility in Rockville, Maryland. The base period of performance is 12 months...

The National Institutes of Health National Institute on Drug Abuse awarded a $535,550 firm fixed price purchase order to Axion Biosystems, Inc. for the acquisition of a Maestro APEX automated incubator system and a Maestro MEA 768-channel multi-well system. The systems will support NIDA's therapeutic development programs, as solicited in the combined synopsis and solicitation seeking offers for the goods and services. Axion Biosystems will provide the Maestro systems, four days of installation...